Literature DB >> 7253137

Clinical manifestations of toxic shock syndrome.

P J Chesney, J P Davis, W K Purdy, P J Wand, R W Chesney.   

Abstract

Twenty-two women aged 13 to 44 years (mean, 22 years) with toxic shock syndrome (TSS) were hospitalized in Madison, Wis, between Aug 1, 1977, and Sept 1, 1980. Disease onset occurred during menses in 21 patients; all recovered. Notable sequelae included vocal cord paralysis and impaired finger sensation in two patients and recurrent disease in three. Coagulase-positive staphylococci were grown from the cervix or vagina in 11 of 12 women cultured. Previously undescribed features included vulvar cellulitis, hypocalcemia, hypophosphatemia, hypocholesterolemia, hyponatremia, lymphocytopenia, hypoferrinemia, and late convalescent hair and nail loss. Patients requiring dopamine hydrochloride had worse renal function, longer hospitalizations, and higher total serum bilirubin levels, and clinical onset earlier in menses. Originally reported in children, TSS now appears to be primarily a disease of menstruating women in whom recurrences are possible.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7253137

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  30 in total

1.  Coordinate suppression of superantigen-induced cytokine production and T-cell proliferation by a small nonpeptidic inhibitor of class II major histocompatibility complex and CD4 interaction.

Authors:  T Krakauer
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

2.  Internal medicine-important advances in clinical medicine: toxic shock syndrome.

Authors:  C J Fisher
Journal:  West J Med       Date:  1983-05

Review 3.  Immunoregulatory mechanisms of T-cell-dependent shock induced by a bacterial superantigen in mice.

Authors:  S Florquin; M Goldman
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

4.  Russell Wallace Chesney MD-a fond farewell.

Authors:  Robert Wyatt; Aaron Friedman
Journal:  Pediatr Nephrol       Date:  2015-06-27       Impact factor: 3.714

5.  [Toxic shock syndrome after open ankle fracture].

Authors:  T Klüter; S Fitschen-Oestern; M Weuster; H Fickenscher; A Seekamp; S Lippross
Journal:  Unfallchirurg       Date:  2015-07       Impact factor: 1.000

6.  Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.

Authors:  T Krakauer; B G Stiles
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

7.  Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology.

Authors:  Peter A Szabo; Ankur Goswami; Delfina M Mazzuca; Kyoungok Kim; David B O'Gorman; David A Hess; Ian D Welch; Howard A Young; Bhagirath Singh; John K McCormick; S M Mansour Haeryfar
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

8.  Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo.

Authors:  Teresa Krakauer; Marilyn Buckley; Haleem J Issaq; Stephen D Fox
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

9.  Toxic shock syndrome in a patient with systemic lupus erythematosus.

Authors:  R M Chan; H R Graham; C L Birmingham
Journal:  Can Med Assoc J       Date:  1983-12-01       Impact factor: 8.262

10.  Postoperative cauda syndrome caused by Staphylococcus aureus.

Authors:  S M Arend; A V Steenmeyer; P C Mosmans; H A Bijlmer; J W van't Wout
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.